North America Medical Second Opinion Market Report Scope & Overview:

The North America Medical Second Opinion Market size was valued at USD 3.22 Billion in 2025 and is expected to reach USD 12.62 Billion by 2035, at 14.64% CAGR from 2026-2035

The North America Medical Second Opinion Market is expanding as large employer-sponsored benefit programs and a dense concentration of leading academic medical centers continue reinforcing the region's position as the largest current second-opinion market worldwide. Growing insurer willingness to commission independent specialist review for high-cost oncology and cardiac procedures is sustaining demand across both the United States and Canada, while mature telehealth infrastructure continues removing geographic barriers that once limited specialist access outside major metropolitan areas.

Leading domestic second-opinion providers continue expanding specialist-matching technology to handle rising referral volumes without proportionally growing physician headcount, and growing collaboration between health systems and dedicated second-opinion vendors is further strengthening regional service capacity. Canadian insurers are also beginning to expand coverage for specialist second-opinion services, broadening the region's addressable base beyond employer-sponsored U.S. plans, while growing patient awareness of second-opinion rights continues reinforcing utilization across both countries.

⮞In March 2025, UAB Medicine launched its Online Second Opinion service, enabling patients and clinicians outside its health system to submit cases securely for specialist review. The service particularly targets complex, rare, cancer and neurological conditions, broadening remote access to academic medical expertise across North America.

Global Medical Second Opinion Market Size

The Global Medical Second Opinion Market was valued at USD 8.36 Billion in 2025 and is projected to reach USD 34.57 Billion by 2035, growing at a CAGR of 15.30% from 2026 to 2035. The growth of this market is mainly driven by rising employer-sponsored benefit adoption and growing insurer use of independent specialist review for high-cost procedures.

US Medical Second Opinion Market Size Outlook

The US Medical Second Opinion Market was valued at approximately USD 2.65 billion in 2025 and is projected to reach approximately USD 10.29 billion by 2035, registering a CAGR of approximately 14.52% from 2026 to 2035.

Demand across the United States continued to be shaped by Teladoc Health's expanded Expert Medical Opinion coverage, a large base of employer-sponsored benefit programs and growing insurer willingness to commission independent specialist review for high-cost oncology and cardiac cases. Rising investment in digital referral infrastructure reinforced the country's position as the largest national market for second-opinion services tracked in this report, while Cleveland Clinic's enhanced remote consultation platform further strengthened sustained domestic demand. Employers, health systems and insurers increasingly prioritized faster specialist turnaround alongside cost containment across both in-house and outsourced second-opinion channels.

⮞In March 2026, Cedars-Sinai expanded its Virtual Second Opinion program to residents of 39 U.S. states, providing remote access to more than 150 specialists across over 600 conditions. Participants can obtain a detailed written clinical review without traveling to the California medical center.

By Type, Hospital Physicians/Specialties Dominates the North America Medical Second Opinion Market and Medical Second Opinion Companies Grows Fastest

Hospital Physicians/Specialties retained the largest type share across North America, reflecting the region's dense concentration of named-physician programs tied to oncology, cardiology and neurology service lines at leading academic medical centers. Large U.S. and Canadian hospital systems continue using these programs as a retention tool for complex-case patients who might otherwise seek review from an outside third-party network. Deep institutional reputation and subspecialist depth at established centers further reinforce this channel's dominant position, particularly for rare or high-acuity diagnoses requiring narrow subspecialty expertise.

Medical Second Opinion Companies are forecast to grow fastest as dedicated platforms increasingly compete with hospital-affiliated channels for employer and insurer contracts across the region. U.S. and Canadian employers increasingly favor these vendors for standardized turnaround times and documentation across a national specialist panel. Growing venture investment in regional second-opinion-focused health-technology platforms is further accelerating specialist-matching capability relative to legacy hospital referral pathways across both countries. Expanding case-management software and AI-assisted triage tools are additionally lowering the per-case cost of operating a large, cross-border specialist panel spanning both U.S. and Canadian jurisdictions, widening the pool of vendors able to compete for large employer contracts.

⮞In June 2026, Cambridge-based Genomate Health launched a physician-led, AI-supported cancer second-opinion service in 11 U.S. states. The telehealth offering uses patients' tumor genomic data to inform specialist review of treatment options, illustrating the growth of dedicated technology-enabled second-opinion providers.

By Source of Service, In-House Dominates the North America Medical Second Opinion Market and Outsourced Grows Fastest

In-House second-opinion review dominated North America as large hospital systems and integrated health networks continue routing requests to employed specialists rather than external panels. Keeping review in-house allows these systems to retain the referral and the associated treatment revenue, a strong incentive reinforced by established electronic health record integration across U.S. and Canadian institutions. Workforce expertise accumulated at existing academic centers further discourages a shift toward external review pathways for core, high-volume specialties.

Outsourced second-opinion review is forecast to grow fastest as smaller U.S. and Canadian hospital systems and employers increasingly rely on external specialist networks rather than building comparable in-house capability. Employers without access to a large academic medical center of their own are increasingly contracting dedicated vendors to offer comparable specialist access. Growing insurer willingness across the region to commission outsourced review for high-cost cases is further reinforcing this channel's above-average growth trajectory. Rising use of dual-sourcing arrangements, where insurers contract more than one vendor to manage surge volumes and coverage gaps across both countries, is further widening the addressable market for outsourced providers across the United States and Canada alike.

⮞In June 2026, Dialogue Health Technologies introduced its Medical Second Opinion program for Canadian employers, insurers and plan sponsors. The service provides outsourced reviews through Canadian specialists, supported by dedicated care coordinators and an academic partner network, and was accessible to more than one million Canadians at launch.

By Application, Cancer Dominates the North America Medical Second Opinion Market and Neurological Disorders Grows Fastest

Cancer applications dominated North American demand, reflecting the high stakes and treatment variation associated with an oncology diagnosis across both the United States and Canada. Patients and families remain especially motivated to confirm a diagnosis and treatment plan before proceeding with surgery, chemotherapy or radiation, reinforcing oncology's position as the largest single application tracked in this report. Growing availability of molecular and genomic testing is further increasing the complexity of oncology cases referred for specialist review across the region.

Neurological Disorders applications are forecast to grow fastest as rising diagnosis rates for complex conditions such as epilepsy and movement disorders increasingly prompt U.S. and Canadian patients to seek subspecialist confirmation. Growing availability of neurology subspecialists on dedicated second-opinion platforms is widening patient access to review previously limited to a handful of academic centers. Expanding insurer coverage for neurological second-opinion review across the region is further reinforcing this application's above-average growth trajectory. Growing use of advanced neuroimaging and genetic-testing data in referral packets is further increasing the clinical complexity of neurological cases routed for specialist confirmation across both the United States and Canada.

⮞In February 2026, Sun Life U.S. expanded its Expert Cancer Review service with proactive outreach to eligible members filing cancer-related disability or supplemental health claims. Independent oncology specialists provide documented second opinions, supporting earlier assessment of diagnoses and proposed treatment strategies.

Regional Analysis

US Medical Second Opinion Market Insights

The U.S. dominated the North America Medical Second Opinion Market with the highest revenue share of about 82.35% in 2025, supported by a deep base of leading academic medical centers, large employer-sponsored benefit programs and growing insurer willingness to commission independent specialist review. Teladoc Health's expanded Expert Medical Opinion coverage and Cleveland Clinic's enhanced remote-consultation platform continue reinforcing U.S. leadership across nearly every application tracked in this report. Growing employer recognition of second-opinion benefits as a cost-containment tool has further elevated the strategic priority placed on domestic specialist-review infrastructure.

Continued expansion of employer-sponsored benefit programs, growing insurer-commissioned utilization-management review and sustained investment in digital referral infrastructure reinforce U.S. dominance within North America. Rising adoption of AI-enabled case triage is expected to keep the United States the region's primary revenue engine through the remainder of the decade, with several large health systems expanding named-physician second-opinion programs. Several multi-state health systems are additionally standardizing second-opinion referral workflows across their networks, reinforcing scale advantages that smaller regional providers and Canadian counterparts have yet to match.

Canada Medical Second Opinion Market Insights

Canada is expected to grow at the fastest CAGR of about 15.13% from 2026-2035, facilitated by growing cross-border collaboration with U.S. specialist networks and rising domestic private-insurance coverage for second-opinion services. Federal and provincial healthcare-quality initiatives are reinforcing Canada's above-regional growth trajectory as domestic insurers expand coverage for independent specialist review. Growing collaboration between Canadian employers and U.S.-based second-opinion vendors is further widening the country's addressable client base. Several large Canadian employers are also beginning to pilot dedicated second-opinion benefits for employees facing complex oncology and cardiac diagnoses, a program design borrowed directly from established U.S. employer-benefit models.

Continued investment by regional providers in Canadian distribution and technical-support infrastructure, combined with growing interest from domestic private insurers, is supporting faster-than-average volume growth across the country through the forecast period. Expanding cross-border referral coordination is expected to reinforce this pattern through the remainder of the decade as Canadian providers continue aligning quality and credentialing practices with U.S. requirements. Growing provincial interest in formalizing second-opinion access within supplementary health benefits is additionally widening the pool of Canadian patients able to access specialist review without paying entirely out of pocket.

⮞In July 2025, Sun Life Canada announced Medical Second Opinion by Dialogue through its Lumino Health Virtual Care platform, allowing eligible members to request expert review of an existing diagnosis or treatment plan. The offering also integrates care navigation and specialist-finding support within group benefits.

Market Dynamics

Growth Drivers: Employer-Benefit Expansion and Sustained Oncology and Cardiac Demand

The North American industry is driven by growing employer-sponsored second-opinion benefit adoption, sustained oncology, cardiac and neurological review volumes, and rising insurer interest in independent specialist review as a utilization-management tool. As health systems and payers prioritize both cost containment and improved treatment accuracy, demand for domestic second-opinion capacity continues rising across the United States and Canada.

Growing AI-enabled case triage, reinforced by Teladoc Health's and Cleveland Clinic's platform expansions, is reinforcing this driver by giving providers flexible access to larger referral volumes without proportional headcount growth. Expanding collaboration between health systems and dedicated second-opinion vendors is further widening the addressable client base across the region.

⮞June 2025: The Clinic by Cleveland Clinic reported extending physician licensing coverage and introducing concierge cancer-care services for its virtual second-opinion offering. The expansion was designed to improve nationwide specialist availability for health plans, employers and patients making complex treatment decisions.

Restraints: Cross-Border Licensing Complexity and Reimbursement Variability

Licensing fragmentation across U.S. states and between the United States and Canada continues restraining faster capacity expansion, as physicians providing remote second-opinion review must often hold licensure in the patient's home jurisdiction. Limited availability of highly specialized subspecialists, particularly in rare-disease and complex oncology fields, further constrains how quickly providers can expand case-handling capacity without compromising review quality.

Reimbursement variability across U.S. payers and Canadian provincial health plans also complicates capacity expansion decisions, as insurance coverage for second-opinion services differs considerably by jurisdiction. Because new specialist-credentialing cycles can take considerable time, some providers continue favoring partnerships with existing credentialed networks over building entirely new physician panels.

Opportunities: Canadian Coverage Expansion and AI-Enabled Case Triage

Growing Canadian private-insurance coverage for independent specialist review represents a significant opportunity, as domestic insurers increasingly recognize second-opinion programs as a proven cost-containment mechanism already validated across the U.S. market. Providers positioned early in this emerging coverage expansion stand to capture meaningful share as Canadian adoption broadens through the forecast period.

Expansion of AI-enabled case triage and specialist-matching technology offers a second opportunity for North American providers able to differentiate on turnaround speed rather than network size alone. Continued collaboration between insurers and dedicated second-opinion vendors is expected to further accelerate this opportunity through the remainder of the forecast period.

⮞In March 2026, The United Church of Canada integrated Novus Health medical second-opinion requests into its GreenShield+ telemedicine benefits pathway, following a January provider transition. Members gained an online referral route to independent clinical review, demonstrating how Canadian plan sponsors can expand access through existing digital-benefits platforms.

North America Medical Second Opinion Market Companies are:

• Teladoc Health

• Included Health

• 2nd.MD

• Cleveland Clinic

• Mayo Clinic

• Johns Hopkins Medicine International

• Cigna Healthcare

• Optum

• HCA Healthcare

• MDLIVE

• WorldCare International

• AXA Health

• PinnacleCare International

• Alight Solutions

• MORE Health

• Sun Life Health Navigator

• Accolade

• Medisense Healthcare Solutions

• Global Second Opinion

• Second Opinion International

North America Medical Second Opinion Market Report Scope: